Month: October 2025
-
Andarix Pharmaceuticals CEO to Present on Building High-Value Biotechnology Companies at Outsourcing in Clinical Trials New England Conference
FOR IMMEDIATE RELEASE October 16, 2025 Contact:Andarix Pharmaceuticals617-957-9858info@andarix.com Presentation Highlights Essential Tools and Strategies for Successful Biotech Company Formation BOSTON, MA – October 16, 2025 – Andarix Pharmaceuticals, a clinical-stage biopharmaceutical company developing next-generation targeted radiotherapeutics for oncology, announced today that Chief Executive Officer Chris Adams will present on the essential tools and strategies needed…
-
Andarix Pharmaceuticals Advances Targeted Peptide Therapy Platform for Rare Cancers
CEO to Present at Major Industry Summit as Company Gains Momentum in Personalized Cancer Treatment BOSTON – July 23, 2025 – Andarix Pharmaceuticals, a clinical-stage biotechnology company pioneering targeted peptide therapies for rare cancers, today announced that CEO Chris Adams will present at the 3rd Targeted Radiopharmaceuticals Supply Chain & Manufacturing Summit in Boston on July 23-24, 2025.…